ARTICLES
FDA grants Fast Track Designation to E2609 for Alzheimer's
November 18, 2016
EMA to revise first-in-human clinical trials guideline
November 18, 2016
Syntimmune appoints David De Graaf CEO
November 18, 2016
Engaging patients for a more successful clinical trial
November 15, 2016
Upcoming Events
-
21Oct